Use of myostatin (gdf-8) antagonists for treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61K 39/395 (2006.01) A61K 48/00 (2006.01) A61P 21/00 (2006.01)

Patent

CA 2597152

The present invention relates to a method of treating sarcopenia in a human or animal patient by inhibiting the activity of myostatin using one or more myostatin antagonists.

La présente invention concerne un procédé pour traiter la sarcopénie chez un patient humain ou un animal en bloquant l'activité de la myostatine au moyen d'un ou plusieurs antagonistes de myostatine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of myostatin (gdf-8) antagonists for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of myostatin (gdf-8) antagonists for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of myostatin (gdf-8) antagonists for treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1644616

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.